Susquehanna International Group’s Kezar Life Sciences KZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,259
Closed -$9.38K 12750
2024
Q3
$9.74K Sell
1,259
-27,713
-96% -$167K ﹤0.01% 11725
2024
Q2
$174K Buy
28,972
+23,640
+443% +$180K ﹤0.01% 10539
2024
Q1
$48.1K Sell
5,332
-3,209
-38% -$29.2K ﹤0.01% 11577
2023
Q4
$80.9K Buy
8,541
+2,959
+53% +$26K ﹤0.01% 11470
2023
Q3
$66.4K Sell
5,582
-2,189
-28% -$38.8K ﹤0.01% 11156
2023
Q2
$190K Sell
7,771
-10,501
-57% -$273K ﹤0.01% 10326
2023
Q1
$572K Buy
18,272
+14,730
+416% +$852K ﹤0.01% 8242
2022
Q4
$249K Sell
3,542
-5,720
-62% -$424K ﹤0.01% 9556
2022
Q3
$797K Sell
9,262
-1,830
-16% -$178K ﹤0.01% 7234
2022
Q2
$917K Buy
11,092
+4,491
+68% +$396K ﹤0.01% 6746
2022
Q1
$1.1M Buy
6,601
+1,323
+25% +$190K ﹤0.01% 6872
2021
Q4
$882K Buy
+5,278
New +$596K ﹤0.01% 7621
2021
Q2
Sell
-3,040
Closed -$181K 12949
2021
Q1
$181K Buy
3,040
+1,527
+101% +$89.3K ﹤0.01% 11505
2020
Q4
$79K Sell
1,513
-144
-9% -$8.01K ﹤0.01% 10598
2020
Q3
$80K Buy
+1,657
New +$79.2K ﹤0.01% 10037
2020
Q2
Sell
-1,134
Closed -$57.2K 10550
2020
Q1
$49K Buy
+1,134
New +$46.1K ﹤0.01% 9693

Other funds holding KZR

Susquehanna International Group's KZR Position: Q4 2024 in Review

Susquehanna International Group sold out of Kezar Life Sciences (KZR) in Q4 2024, closing a stake of 1,259 shares — an estimated $9.38K sold.

Susquehanna International Group first reported a position in KZR in Q1 2020 and held it in 16 quarters. The position peaked at $1.1M in Q1 2022. 43 funds tracked by Wall St. Rank hold KZR as of Q4 2024.

  • Susquehanna International Group reported no remaining Kezar Life Sciences position as of Q4 2024 after selling out during the quarter.
  • Susquehanna International Group sold 1,259 Kezar Life Sciences shares in Q4 2024, an estimated $9.38K.
  • Susquehanna International Group first reported a position in Kezar Life Sciences in Q1 2020 and held it in 16 quarters.
  • Susquehanna International Group's Kezar Life Sciences position peaked at $1.1M in Q1 2022.
  • 43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2024.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.